BJ resists dysentery through the NF-κB and Nrf2 signaling pathways (Li et al., 2018; Zhou et al., 2018; Zheng et al., 2021)[25] and is used to treat genital warts by regulating the expression of TLR4 receptors (Weiqi et al., 2023). The gene discussed is NFKB1; the disease is anogenital human papillomavirus infection.